Almost half of the patients with diabetes were treated with metformin alone (47%), 42% with metformin and insulin, 5% with sulfonylurea only, 3% with an SGLT-2 inhibitor only, and 3% with diet only. The gene discussed is SLC5A2; the disease is diabetes mellitus.